Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Adagio Medical Holdings, Inc.ADGM · Entity 7926 | Chief Financial Officer | March 06, 2026 | March 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Adagio Medical Holdings, Inc.
Report date March 06, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.98 · Expires 2036-03-06 | Direct | 490,500 |
Reported balance
After 2026-03-06 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-06 · Grant · Acquired 490,500 · Balance 490,500 F1: Employee Stock Options granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest over a four-year period, whereby twenty-five percent (25%) of the Option will vest on October 20, 2026, with the remaining shares subject to the Option vesting in thirty-six (36) equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Employee Stock Options granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest over a four-year period, whereby twenty-five percent (25%) of the Option will vest on October 20, 2026, with the remaining shares subject to the Option vesting in thirty-six (36) equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2026 Filed Mar 9, 2026 10:04 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantEmployee Stock Options (Right to Buy) · Derivative | 490,500 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0002089223-26-000002 · form4-03092026_100328.xml · derivative · entry 1 Kaster Deborah · CIK 0002089223 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 490,500 Underlying: Common Stock · 490,500 shares Expires 2036-03-06 F1 · derivative.exercise_date: Employee Stock Options granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest over a four-year period, whereby twenty-five percent (25%) of the Option will vest on October 20, 2026, with the remaining shares subject to the Option vesting in thirty-six (36) equal monthly installments thereafter. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 11:00 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | PurchaseCommon Stock | 15,000 | $1.20 | $17,973.00 |
DisclosureSEC source: 0002089223-25-000002 · form4-12182025_061201.xml · nonDerivative · entry 1 Kaster Deborah · CIK 0002089223 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 F1 · kind: Open market purchase. F2 · price: This transaction was executed in multiple trades at prices ranging from $1.11 to $1.20. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.